Fda Approves Abbvie's Hepatitis Treatment

U.S. regulators on Friday approved AbbVie Inc.’s new multidrug regimen for hepatitis C, the latest in a wave of new medicines that is transforming treatment of the liver disease.

Topics:  abbvie   hepatitis   treatment   
BING NEWS:
  • FDA Approves Merck’s New Drug For A Rare Lung Disease
    The pharmaceutical giant’s new treatment, sotatercept, showed significant benefits for the thousands of patients suffering from pulmonary arterial hypertension in clinical trials. Nearly 40,000 ...
    03/26/2024 - 10:09 am | View Link
  • AbbVie’s New ‘Biological Missile’ Ovarian Cancer Treatment Gets Full FDA Approval
    Elahere was developed by ImmunoGen, but became part of AbbVie’s portfolio after AbbVie acquired ImmunoGen for $10 billion last November. AbbVie’s purchase of ImmunoGen and Elahere specifically ...
    03/22/2024 - 10:29 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News